Cardinal Health Inc. closed 4.35% short of its 52-week high of $132.84, which the company achieved on January 30th.

Dublin, Ohio-based Cardinal Health, Inc. (CAH) manufactures and distributes pharmaceuticals, medical & laboratory products, ...

Jefferies has upgraded Cardinal Health (CAH) to buy from hold, citing management's emerging EPS track record. Read more here.

Medtech companies have their eye on the growing hospital-at-home market, which is driven largely by the rising elderly ...

Wells Fargo analyst Stephen Baxter maintained Cardinal Health with an Equal-Weight and raised the price target from $135 to ...

Cardinal Health’s acquisition of Advanced Diabetes Supply Group hasn’t closed yet, but company officials said on a conference call to discuss second quarter financial results that ...

Jefferies analyst Brian Tanquilut upgraded Cardinal Health (CAH) to Buy from Hold with a price target of $150, up from $140. The firm thinks ...

Shares of Cardinal Health Inc. CAH advanced 1.82% to $127.45 Wednesday, on what proved to be an all-around great trading ...

Jefferies Financial Group upgraded shares of Cardinal Health (NYSE:CAH – Free Report) from a hold rating to a buy rating in a report released on Wednesday morning, Marketbeat reports.